Burcon NutraScience Corp.
- WKN: 157793
- ISIN: CA1208311029
- Land: Kanada
Nachricht vom 14.02.2018 | 19:09
Burcon NutraScience Corp.: BURCON ANNOUNCES COMPLETION OF RIGHTS OFFERING
DGAP-News: Burcon NutraScience Corp. / Key word(s): Capital Increase
BURCON ANNOUNCES COMPLETION OF RIGHTS OFFERING
Vancouver, British Columbia, February 14, 2018 - Burcon NutraScience Corporation (TSX:BU, NASDAQ:BUR) ("Burcon" or the "Company") is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00pm (EST) on February 13, 2018. The Rights Offering will result in the issuance of 6,114,361 common shares of Burcon ("Common Shares") at a price of $0.57 per share for gross proceeds of approximately $3.49 million.
Burcon is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and the additional subscription privilege in connection with the Rights Offering and will provide further details, including information required by National Instrument 45-106 - Prospectus Exemptions, once available.
Further to the Company's press release of February 5, 2018 regarding the transfer of its listing to the NASDAQ Capital Market from the NASDAQ Global Market, Burcon confirms that, as a result of the Rights Offering, it has stockholders' equity of over US$2.5 million, which meets the stockholders' equity requirement for listing on the NASDAQ Capital Market.
About Burcon NutraScience Corporation
Burcon is a leader in developing technologies for the production of valuable plant-sourced ingredients for use in food, nutrition, wellness and supplement products. The company has developed a portfolio of composition, application, and process patents originating from a core protein extraction and purification technology. Burcon's CLARISOY(TM) soy protein offers clarity and high-quality protein nutrition for low pH beverage systems and excellent solubility and exceptionally clean flavor at any pH; Peazazz(R) is a uniquely soluble and clean-tasting pea protein; and Puratein(R), Supertein(R) and Nutratein(R) are canola protein isolates with unique functional and nutritional attributes. Burcon is also conducting research to develop extraction and isolation processes for the production of purified cannabinoid extracts from cannabis and other organic source materials. For more information about the company, visit www.burcon.ca.
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward- looking statements or forward-looking information can be identified by words such as "anticipate," "intend," "plan," "goal," "project," "estimate," "expect," "believe", "future," "likely," "may," "should," "could", "will" and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding the ability of the Company to maintain compliance with the continued listing requirements of the Nasdaq Capital Market and other expectations, intentions and plans contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the actual results of business negotiations, marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form dated June 21, 2017 filed with the Canadian securities administrators on www.sedar.com and contained in Burcon's 20-F filed with the U.S. Securities and Exchange Commission on www.sec.gov. Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.
CLARISOY is a trademark of Archer Daniels Midland Company.
Media & Industry Contact:
Burcon NutraScience Corp.: Burcon to Participa ...
Burcon NutraScience Corporation Announces Clos ...
Burcon NutraScience Corp.: Burcon Commences Tr ...
Burcon NutraScience Corp.: Burcon NutraScience ...
Burcon NutraScience Corp.: Burcon, Merit and N ...
MBH Corporation. Hohes Kurspotenzial
Die MBH Corporation plc hat in den vergangenen Berichtsperioden eine sehr hohe M&A-Aktivität aufgezeigt. Unter Anwendung der so genannten Agglomeration Methodology hat die Beteiligungsgesellschaft branchenübergreifend seit 2018 11 Beteiligungen erworben. Bei einem Pro-Forma-Umsatz der Beteiligungsgesellschaften von über 120 Mio. GBP und einem Pro-Forma-EBITDA in Höhe von über 11 Mio. GBP weist die MBH derzeit eine Marktkapitalisierung von umgerechnet gerade einmal 19,8 Mio. GBP auf. Ausgehend vom aktuellen Aktienkurs liegt zu unserem Kursziel in Höhe von 1,95 € ein hohes Kurspotenzial vor
Der AKTIONÄR News
02. April 20:33 Überraschung: Tesla mit Rekordquartal dank Model Y und 3
02. April 19:20 DAX, Dow Jones & Co: Die Mutter aller Rezessionen – ...
02. April 19:18 Alibaba: Dieses Geschäft ist ein Karriere-Killer
News im Fokus
Beiersdorf Aktiengesellschaft: Auswirkungen der Corona-Krise auf Geschäftsentwicklung 2020 - Beiersdorf nimmt Prognose für das Geschäftsjahr 2020 zurück
02. April 2020, 18:33
Fourth Quarter Fiscal Year 2020 Results
06. April 2020
Original-Research: Valneva SA (von First Berlin Equity Research GmbH): Kaufen Valneva SA
02. April 2020